Expression of NK (CD16+56+) and B cells (CD19) Receptor Molecules as a Reliable Clinical Response Biomarkers of SLE and RA Patients Under the Rituximab Treatment
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.